Isorhamnetin as a potential therapeutic agent for diabetes mellitus through PGK1/AKT activation

.

Source: Archives of Physiology and Biochemistry - March 6, 2024 Category: Physiology Authors: Abdelrahim AlqudahEsam QnaisMohammed AlqudahOmar GammohMohammed WedyanShtaywy S. Abdallaa Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordanb Department of Biology and Biotech Source Type: research